Johnson & Johnson xStock 

JNJX Price

What is Johnson & Johnson xStock (JNJX), the tokenized JNJ stock?

Johnson & Johnson xStock (JNJx) is a tokenized price tracker for one share of Johnson & Johnson (NYSE: JNJ) — on-chain exposure to the healthcare stock without a brokerage account. Backed Assets (JE) Limited issues JNJx under the xStocks brand as a tracker certificate, not the equity itself. The token is an SPL asset on Solana, with ERC-20 wrappers on Ethereum, BNB Chain, and Arbitrum. DropsTab classifies JNJX under Tokenized Stock.

Is JNJx backed by real JNJ shares?

Yes. Each JNJx token is a tracker certificate referencing one Johnson & Johnson share, with underlying shares held through the issuer's custody chain. Custodians and brokers named in issuer documentation include Alpaca Securities LLC, InCore Bank AG, and Maerki Baumann & Co. AG. JNJx is not a claim on shares held directly by the token holder — redemption runs only through authorized and licensed partners, not open retail redemption.

How do xStocks tokens track the price of Johnson & Johnson stock?

JNJx tracks the JNJ share price through an elastic mint-and-burn mechanism. Authorized partners tokenize deposited shares and mint new JNJx when demand arrives; JNJx is burned and the underlying share released on redemption. JNJx's issuance and redemption flow is designed to keep the token price aligned with the underlying share. JNJx carries ISIN CH1436219294 as a regulated security.

Why does JNJx have no fixed token supply?

JNJx has no fixed maximum supply — the token supply is elastic, expanding and contracting through the mint-and-burn mechanism as licensed partners tokenize deposited JNJ shares or release them on redemption. Any published supply figure is a snapshot that goes stale with the next mint or burn; the live figure sits on the DropsTab page. Because JNJx has no team, investor, or ecosystem allocation, there are no cliffs or scheduled unlocks — supply reflects share tokenization, not insider distribution, so unlock-driven sell pressure does not apply. The relevant supply risk is issuer and custody concentration instead.

Where can I buy JNJX?

Per DropsTab data, JNJx's tracked on-chain market is the Raydium (CLMM) JNJx/USDC pool on Solana, reachable through aggregators such as Jupiter. Centralized access runs through Kraken, which lists JNJx inside its xStocks tokenized-equity product against USD, with on-chain withdrawal via Solana. Kraken's xStock pairs are a venue product wrapper and do not map one-to-one onto the on-chain SPL token.

What are the liquidity risks of trading JNJx on-chain?

The primary on-chain market for JNJx is the Raydium (CLMM) JNJx/USDC pool, and pool depth is thin relative to major tokens. Spreads can widen outside U.S. market hours, when the underlying JNJ share does not trade. CEX availability for JNJx depends on each venue's product wrapper rather than the on-chain SPL token, so on-chain and centralized liquidity are separate books.

Which fees apply to JNJx?

Per issuer documentation, JNJx currently carries no management fee, though the terms allow up to 0.25% per year. Issuance and redemption can each cost up to 0.50% on entry or exit. Secondary trading on Raydium or through a venue's xStocks product incurs that venue's own trading fees instead.

Do JNJX holders receive Johnson & Johnson shareholder rights?

No. JNJx tokens generally carry no shareholder voting rights in Johnson & Johnson — the token packages price exposure into a tracker certificate, not direct equity ownership. Holders cannot vote on Johnson & Johnson corporate matters. Converting JNJx back into underlying shares runs only through authorized partners.

Can U.S. persons buy JNJX?

No. JNJx is not registered under the U.S. Securities Act of 1933, and issuer terms exclude U.S. persons and U.S. addresses. UK clients face separate restrictions under issuer legal notices. Access is limited to eligible investors in permitted jurisdictions, onboarded through licensed distribution entities.